onclive.com rank 26 |
Number of domains linking to onclive.com 13 | semantic flow 8.26 |
Number of links to onclive.com 130 | semantic flow 8.26 |
Number of domains linked from onclive.com 2 | semantic flow 0.5 |
Number of links from onclive.com 8 | semantic flow 0.5 |
Pages with highest topical PageRank pointing to domain.
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Dr. Karasic on Palbociclib in Esophageal and Gastric Cancer http://www.onclive.com/onclive-tv/dr-karasic-on-palbociclib-in-esophageal-and-gastric-canc | 0.28 | 0.98 | 103 | 33 | 2 | 1 | 0 | 0 | |
Active Surveillance Underused in Prostate Cancer Patients Who Want to Preserve Sexual Function http://www.onclive.com/web-exclusives/active-surveillance-underused-in-prostate-cancer-pat | 0.28 | 0.93 | 102 | 32 | 2 | 2 | 0 | 0 | |
Dr. Haldorsen on the Importance of Imaging in the Diagnosis of Endometrial Cancer http://www.onclive.com/onclive-tv/dr-haldorsen-on-the-importance-of-imaging-in-the-diagnos | 0.28 | 1 | 102 | 31 | 1 | 1 | 0 | 0 | |
Dr. Huang on the Widespread Adoption of Robotic Surgery for Bladder Surgery http://www.onclive.com/onclive-tv/dr-huang-on-the-widespread-adoption-of-robotic-surgery-f | 0.28 | 0.94 | 104 | 35 | 2 | 1 | 0 | 0 | |
Dr. Janjigian on Immunotherapy in Esophageal and Gastric Cancer http://www.onclive.com/onclive-tv/dr-janjigian-on-immunotherapy-in-esophageal-and-gastric- | 0.28 | 0.98 | 103 | 31 | 2 | 1 | 0 | 0 | |
Dr. Lagunes on Potential Combinations in the Treatment of Patients With NETs http://www.onclive.com/onclive-tv/dr-lagunes-on-potential-combinations-in-the-treatment-of | 0.28 | 0.94 | 104 | 29 | 2 | 1 | 0 | 0 | |
Dr. Slovin Discusses a Study Comparing Cardiovascular Events With Degarelix, Leuprolide in Prostate Cancer http://www.onclive.com/conference-coverage/gu-2018/dr-slovin-discusses-a-study-comparing-c | 0.28 | 0.97 | 96 | 29 | 1 | 1 | 0 | 0 | |
Ramucirumab/Durvalumab Combination Shows Antitumor Activity in Gastric and GEJ Cancer http://www.onclive.com/conference-coverage/gi-2018/ramucirumabdurvalumab-combination-shows | 0.28 | 0.92 | 104 | 32 | 3 | 2 | 0 | 0 | |
Antibody Selection and Tumor Sidedness in CRC http://www.onclive.com/inside-oncology/crc-management/antibody-selection-and-tumor-sidedne | 0.28 | 0.7 | 89 | 25 | 2 | 1 | 0 | 0 | |
Dr. Hensley on dMRR and MSI-H Testing in Endometrial Cancer http://www.onclive.com/onclive-tv/dr-hensley-on-dmrr-and-msih-testing-in-endometrial-cance | 0.21 | 0.99 | 103 | 34 | 1 | 1 | 0 | 0 |
Relevant domains with most links to selected domain.
Relevant domains with most links from selected domain.
domain | |||
---|---|---|---|
http://gotoper.com/ | 7 | 0.43 | gotoper.com |
http://giantsofcancercare.com/ | 1 | 0.07 | giantsofcancercare.com |
Pages from domain with most relevant inbound links.
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.onclive.com/onclive-tv/dr-bardia-on-sacituzumab-govitecan-in-triplenegative-bre | 33 | 0.15 | 0.91 | 2.02 | 0.94 | yes | 103 | 33 | 2 | 1 | 1 | 1 | |
http://www.onclive.com/specialty/womens-cancer | 16 | 0.15 | 0.97 | 1.09 | 0.99 | yes | 122 | 40 | 1 | 1 | 0 | 0 | |
http://www.onclive.com/specialty/genitourinary-cancer | 9 | 0.15 | 0.97 | 0.6 | 0.99 | yes | 128 | 42 | 1 | 1 | 0 | 0 | |
http://www.onclive.com/conference-coverage/gu-2018/pembrolizumab-survival-benefit-sustaine | 8 | 0.15 | 0.97 | 0.34 | 0.77 | yes | 102 | 35 | 1 | 1 | 0 | 0 | |
http://www.onclive.com/specialty/cancer-pathways | 7 | 0.15 | 0.97 | 0.47 | 0.97 | yes | 127 | 39 | 1 | 1 | 0 | 0 | |
http://www.onclive.com/specialty/personalized-medicine | 7 | 0.15 | 0.97 | 0.45 | 0.96 | yes | 128 | 36 | 1 | 1 | 0 | 0 | |
http://www.onclive.com/specialty/colorectal-cancer | 6 | 0.15 | 0.98 | 0.42 | 0.99 | yes | 128 | 36 | 1 | 1 | 0 | 0 | |
http://www.onclive.com/web-exclusives/new-model-may-improve-patient-selection-in-breast-ca | 4 | 0.15 | 0.98 | 0.28 | 0.97 | yes | 102 | 35 | 3 | 2 | 0 | 0 | |
http://www.onclive.com/onclive-tv/dr-blackwell-discusses-tucatinib-in-her2-breast-cancer | 2 | 0.15 | 0.96 | 0.15 | 1 | yes | 103 | 34 | 2 | 1 | 0 | 0 | |
http://www.onclive.com/specialty/melanoma | 2 | 0.15 | 0.97 | 0.11 | 0.86 | yes | 128 | 32 | 1 | 1 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.